Creon DR 24,000 unit capsule UU 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FG2VW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,072
Award facts
- Contract value 100% obligated
- $1,072.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 24,000 unit capsules of Creon (pancrelipase) in 100-unit quantities, valued at $1,072.14. This non-competitive, firm fixed-price delivery order was awarded on January 2, 2026, with an ultimate completion date of January 5, 2026. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary operations. This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp fulfills a critical role in the federal medical procurement system, particularly supporting the Defense Health Agency and broader military healthcare supply chains. The company's federal contract portfolio demonstrates extensive experience delivering a wide range of pharmaceutical products across multiple therapeutic domains to support military and veteran healthcare systems. The DLA's reliance on AmerisourceBergen Drug Corp through its prime vendor contract reflects the company's capability to meet federal procurement requirements and its established position as a strategic supplier within the military pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FG2VW?
SPE2DR26FG2VW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26FG2VW worth?
The government has obligated $1,072 on SPE2DR26FG2VW.
Is contract SPE2DR26FG2VW an order under another contract?
Yes. SPE2DR26FG2VW is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG2VW competed?
The extent of competition for SPE2DR26FG2VW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award